Incidence of local complications and risk factors associated with peripheral intravenous catheter in neonates * Extracted from the dissertation "Complicações relacionadas ao uso do cateter intravenoso periférico em neonatos", Universidade Federal do Paraná, 2013. ABSTRACT Objective:To evaluate the incidence of complications related to the use of peripheral intravenous catheter in neonates and identify the associated risk factors. Method: Prospective cohort study conducted in a Neonatal Intensive Care Unit. Participants were the hospitalized neonates undergoing peripheral intravenous puncture in the period from February to June 2013. Results: The incidence of complications was 63.15%, being infiltration/extravasation (69.89%), phlebitis (17.84%) and obstruction (12.27%). The risk factors were the presence of infection (p = 0.0192) and weight at the puncture day (p = 0.0093), type of intermittent infusion associated with continuous infusion (p <0.0001), endotracheal intubation (p = 0.0008), infusion of basic plan (p = 0.0027), total parenteral nutrition (P = 0.0002), blood transfusion associated with other infusions (p = 0.0003) and other drugs (p = 0.0004). Higher risk of developing complications in the first 48 hours after puncture. Conclusion: A high rate of complications related to the use of peripheral intravenous catheter, and risk factors associated with infection, weight, drugs and infused solutions, and type of infusion. DESCRIPTORS
Objective:analyze the risk factors linked to complications in peripheral intravenous catheters. Method:secondary data analysis of a randomized controlled trial with 169 medical and surgical patients placed in two groups, one with integrated safety catheter (n=90) and other using simple needle catheter (n=79), with three months follow-up time. Results:the risk factors that raised the odds of developing complications were: hospitalization between 10-19 days (p=0.0483) and 20-29 days (p=0,0098), antimicrobial use (p=0.0288) and use of fluid solutions (p=0.0362). The 20 Gauge lowered the risks of complications (p=0.0153). Multiple analysis showed reduction of risk for the 20 Gauge (p=0.0350); heightened risk for solutions and fluids (p=0.0351) and use of corticosteroids (p=0.0214). Conclusion:risk factors linked to complications in peripheral intravenous catheters were: hospitalization periods between 10-29 days, antimicrobial infusion, solutions and fluids and corticosteroids. Regarding complications, 20 Gauge is a protecting factor compared with 22. Brazilian Clinical Trials Registry: RBR-46ZQR8.
Objective: To analyze the complications deriving from the use and type of peripheral venous catheter in adults. Methods: Randomized clinical trial; undertaken at a teaching hospital between 2012 and 2015; 169 adults were included who were hospitalized at clinical and surgical services and needed peripheral venipuncture with an expected dwelling time of more than 96 hours. Through systemized randomization, 90 participants were allocated to the trial group (complete safety catheter) and 79 to the control group (short flexible catheter). Results: The general complications rate was 55.62%, with 18.34% of phlebitis, 11.83% infiltration, 11.24% obstruction and 9.47% traction. No significant difference was found between the groups for the occurrence of complications, phlebitis, obstruction and traction. Conclusion: The complication rate in peripheral venous catheterization was high but, when compared, without a statistically significant difference, the complete safety catheter showed lower complication rates after the fourth day of survival. ResumoObjetivo: Analisar as complicações decorrentes do uso e tipo de cateter venoso periférico em adultos. Métodos: Ensaio clínico randomizado; realizado em um hospital de ensino, no período de 2012 a 2015; incluiu-se 169 adultos internados em unidades clínicas e cirúrgicas que necessitaram de punção venosa periférica e com permanência prevista de mais de 96 horas. A randomização aleatória sistematizada alocou 90 participantes no Grupo Experimental (cateter de segurança completo) e 79 no Grupo Controle (cateter curto flexível). Resultados: A taxa geral de complicações foi 55,62%, houve 18,34% de flebite, infiltração 11,83%, obstrução 11,24% e tração 9,47%. Não houve diferença significativa entre os grupos para a ocorrência de complicações, flebite, obstrução e tração. Conclusão: A taxa de complicações no cateterismo venoso periférico foi alta, mas quando comparados, sem diferença estatística significativa, o cateter de segurança completo teve taxas menores de complicações após o quarto dia de sobrevida.Brazilian Clinical Trial Registers (ReBEC): RBR-46ZQR8
Incidence of local complications in peripheral venous catheters and associated risk factors
Objective: To evaluate the effectiveness of gauze and tape as compared to transparent polyurethane film for dressing central venous catheters. Methods: A randomized controlled clinical trial was conducted. Results: No significant difference was identified in catheterrelated infection (p = 1) or the stability of the dressing (p = 0.670). There was no statistically significant difference with respect to the absorption of exudate (p <0.001). The likelihood of local reaction in the control group (gauze and tape) was different from the study group (p = 0.024). Conclusion: The type of dressing does not decrease the incidence of catheter-related infection, the binding capacity is similar, and the gauze dressing has the capacity to absorb exudate. However, the gauze dressing resulted in a higher probability of developing a local reaction. Record WHO: ACTRN12609000951257. Keywords: Central venous catheter; Clinical trial; Infection; Bandages RESUMO Objetivo: Avaliar a eficácia dos curativos de gaze e fita e filme transparente de poliuretano para cobertura de cateteres venosos centrais. Métodos: Ensaio clínico controlado randomizado. Resultados: Não foi identificada uma diferença significativa com relação à infecção relacionada ao cateter (p=1) e à fixação do curativo (p=0,670). Foi identificada diferença estatisticamente significativa com relação à absorção de exsudato (p<0,001). A probabilidade de ocorrer reação local no grupo controle é diferente do grupo estudo (p=0,024). Conclusão: O tipo de curativo não diminui a incidência de infecção relacionada ao cateter, a capacidade de fixação é semelhante, o curativo de gaze e fita possui capacidade de absorção de exsudato, porém apresenta probabilidade maior de desenvolver reação local. Registro WHO: ACTRN12609000951257. Descritores: Cateterismo venoso central; Ensaio clínico; Infecção; Bandagens RESUMEN Objetivo: Evaluar la eficacia de las curaciones de gasa y cinta y película transparente de poliuretano para la cobertura de catéteres venosos centrales. Métodos: Ensayo clínico controlado randomizado. Resultados: No se identificó una diferencia significativa con relación a la infección relacionada al catéter (p=1) y a la fijación de la curación (p=0,670). Fue identificada la diferencia estadísticamente significativa con relación a la absorción del exudado (p<0,001). La probabilidad de que ocurra reacción en el lugar en el grupo control es diferente al grupo de estudio (p=0,024). Conclusión: El tipo de curación no disminuye la incidencia de infección relacionada al catéter, la capacidad de fijación es semejante, la curación de gasa y cinta posee capacidad de absorción de exudado, sin embargo presenta probabilidad mayor de desarrollar reacción local. Registro WHO: ACTRN12609000951257.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.